Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Trauma and Acute Care Surgery|June 5, 2026
Finally, a use for balloons: Extended automated endovascular support enhances closed-loop resuscitation in a porcine model of shockElizabeth C Wood, Micaela K Gomez, Magan R Lane, et al.Translational Psychiatry|April 23, 2026
Augmenting extinction with counterconditioning strengthens and sustains neural safety representations in PTSDSamuel E Cooper, Nicole E Keller, Elizabeth A Bauer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancerCarmen J Allegra, Greg Yothers, Michael J O'Connell, et al.Military Medicine|September 23, 2025
Partial Resuscitative Endovascular Balloon Occlusion of the Aorta Versus Intermittent Resuscitative Endovascular Balloon Occlusion of the Aorta in Noncompressible Torso Hemorrhage With Concomitant Traumatic Brain InjuryGloria D Sanin, Elizabeth C Wood, Micaela K Gomez, et al.Breast Cancer Research and Treatment|March 22, 2023
Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41Priya Rastogi, Gong Tang, Saima Hassan, et al.The Lancet. Oncology|October 8, 2013
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trialAndré Robidoux, Gong Tang, Priya Rastogi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trialSandra M Swain, Gong Tang, Charles E Geyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancerEdward H Romond, Jong-Hyeon Jeong, Priya Rastogi, et al.Pageof 8